Driving change through innovation
DIGITAL (Diagnostic, monitoring and treatment of patients with genetic disorders detected through newborn screening and metabolic rare diseases).
The central aim of DIGITAL project is to promote a comprehensive, multi-faceted, yet mutually-reinforcing approach to developing better diagnostic methods, follow-up analytical tests and treatments of inborn errors of metabolism (IEM) diseases.
Enzymlogic will provide access to its expertise in enzymology and to its binding kinetics discovery platform to facilitate the study of how long drugs stay bound to their targets, helping researchers develop more effective treatments for IEMs diseases.
Please submit your request through our Contact us form and we will respond to your inquiry as soon as possible.